Особенности микрометастазирования отечно-инфильтративной формы РМЖ в костный мозг
А. И. Беришвили, Nikolai Nikolaevich Tupitsyn, Лактионов Константин Павлович et al. · Российский биотерапевтический журнал · 2011
IBC is both the least frequent and the most aggressive form of epithelial breast cancer. Because of small number of patients and their heterogeneity, micrometastatic bone narrow involvement in IBC is not investigated in randomized trials and little is known about its influence on disease-free survival and overall survival. In immunocytological study micrometastatic bone narrow involvement was 7 times higher than in standard cytological examination (36,8% vs 5,3%). We found no correlation between histological types of IBC, its hormone receptor status and micrometastatic bone narrow involvement. Our data demonstrated no influence of micrometastatic bone narrow involvement on DFS and OS of patients with IBC.
Cited by 0 works.